Abstract
Tuberculous meningitis (TBM) in children may mimic bacterial meningitis in the early stages. Being a subacute illness, early symptoms may be missed leading to clinical deterioration and late presentation. This review helps to highlight the clinical manifestations, newer diagnostic tests, and newer treatment guidelines of TBM in children. Newer tests like nuclei acid amplification tests (NAATs), line probe assays (LPAs), MGIT, antigen detection, and biomarkers are now available on cerebrospinal fluid (CSF) to aid diagnosis to help provide early management and prevent complications. Recent studies have helped optimize the treatment of TBM to prevent long-term neurological sequelae. Co-infection with HIV requires prompt treatment with anti-tubercular drugs and combination antiretroviral therapy. With early diagnosis and prompt treatment, the risk of death can be reduced and neurological outcome improved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
